Patent Assignment
Reel/Frame 029136/0086
Corrective Assignment to Correct the Name of the Assignee Which Should Be Aryx Therapeutics Previously Recorded on Reel 016571 Frame 0719. Assignor(S) Hereby Confirms the Name of the Assignee Should Have Been Aryx Therapeutics Without the Inc.
Recorded: 2012-10-16
Pages: 4
Assignor
DRUZGALA, PASCAL
Executed: 2005-04-25
Assignee
ARYX THERAPEUTICS
6300 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Property
(1)
Novel Compounds for Treatment of Cardiac Arrhythmia and Methods of Use
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Oct 17, 2012
From: ARYX THERAPEUTICS
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029148/0007 →
Assignment of Assignor's Interest
Oct 22, 2012
From: ARYX THERAPEUTICS, INC.
To: ARMETHEON, INC.
Reel/Frame 029169/0137 →
Release of Security Interest
Feb 6, 2013
From: AYER CAPITAL PARTNERS MASTER FUND, L.P.; MPM BIOVENTURES III, L.P.; MPM BIOVENTURES III-QP, L.P.; MPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KG
To: ARYX THERAPEUTICS, INC.
Reel/Frame 029767/0524 →
Security Interest
Apr 16, 2019
From: ESPERO BIOPHARMA, INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 048918/0544 →
Change of Name
Jul 23, 2020
From: ARMETHEON, INC.
To: ESPERO BIOPHARMA, INC.
Reel/Frame 053293/0930 →
Assignment of Assignor's Interest
Oct 23, 2020
From: ESPERO BIOPHARMA, INC.
To: HESP LLC
Reel/Frame 054150/0011 →